Advertisement

Topics

Global Huntington's Disease Therapeutics Market 20172021 [Report Updated: 02082017] Prices from USD $3500

12:43 EDT 20 Aug 2017 | BioPortfolio Report Blog

About Huntington's Disease Therapeutics

HD is an inherited condition that leads to destruction of nerve cells or neurons. The damage to nerve cells usually causes change in personality, mood swings, irritability and altered behavior. The global HD therapeutics market was witnessing a high unmet demand for disease modifying drug, in the presence of only one approved therapy, Xenazine, and the offlabel use of various different therapeutics. The introduction of AUSTEDO in the market will have a significant impact on the market growth, thereby changing the market dynamics.

Technavio's analysts forecast the global huntington's disease therapeutics market to grow at a CAGR of 14.75% during the period 20172021.

Covered in this report
The report covers the present scenario and the growth prospects of the global huntington's disease therapeutics market for 20172021. To calculate the market size, the report considers sales of branded, generic, and off label drugs.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Huntington's Disease Therapeutics Market 20172021, has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
F. HoffmannLa Roche
H. Lundbeck
Prana Biotechnology
Teva Pharmaceutical Industries
Other prominent vendors
Intellect Neurosciences
Horizon Pharma
Sangamo Therapeutics
Vertex Pharmaceuticals

Market driver
Early onset of disease symptoms, increases the demand for HD therapeutics
For a full, detailed list, view our report

Market challenge
Increase in alternative programs for management of mental disorders
For a full, detailed list, view our report

Market trend
Advances in biomedical sciences
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Original Article: Global Huntington's Disease Therapeutics Market 20172021 [Report Updated: 02082017] Prices from USD $3500

NEXT ARTICLE

More From BioPortfolio on "Global Huntington's Disease Therapeutics Market 20172021 [Report Updated: 02082017] Prices from USD $3500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Huntington's Disease
Huntington's disease is a hereditary disease caused by a defect in a single gene on Chromosome 4 that is inherited in an autosomal dominant fashion. The defect causes a part of DNA, called a CAG repeat, to occur many more times than it is supposed to...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...